From b18eeddff5c78489ddd64d551da7d55c0056e6bd Mon Sep 17 00:00:00 2001 From: Thomas Weber Date: Tue, 8 Aug 2023 13:46:46 +0200 Subject: [PATCH] added other therapy specifics, therapy, therapy relationship, medication and classifiers for them Signed-off-by: Thomas Weber --- ISO/ISO11615-MedicinalProducts.rdf | 198 ++++++++++++++++++++++++++++- 1 file changed, 195 insertions(+), 3 deletions(-) diff --git a/ISO/ISO11615-MedicinalProducts.rdf b/ISO/ISO11615-MedicinalProducts.rdf index 374f2cc2..6d55c633 100644 --- a/ISO/ISO11615-MedicinalProducts.rdf +++ b/ISO/ISO11615-MedicinalProducts.rdf @@ -99,13 +99,14 @@ - + The https://spec.pistoiaalliance.org/idmp/ontology/ISO/20221001/ISO11615-MedicinalProducts.rdf version of this ontology was modified to rename 'ingredient role's to ingredients for clarification and refine the restrictions relating ingredients to pharmaceutical products and manufactured items per discussion at the Pistoia Alliance Conference Workshop on 3 November 2022 (IDMP-298). It was also extended to include concepts such as process, manufacturing process, process identifier, batch, batch identifier, lot, lot number, and others required in support of the regulatory to manufacturing bridge use case. The https://spec.pistoiaalliance.org/idmp/ontology/ISO/20221201/ISO11615-MedicinalProducts.rdf version of this ontology was modified to refactor concepts including substance, moiety, and add physical substance in order to distinguish specifications for substances, which is the primary perspective of the IDMP standards from physical substances, and rename product constituency to product composition, which is better understood by the user community, and to move a couple of restrictions from ingredient to substance, including strength and whether or not that substance is potentially allergenic. (IDMP-405) The https://spec.pistoiaalliance.org/idmp/ontology/ISO/20230201/ISO11615-MedicinalProducts.rdf version of this ontology was modified to integrate additional manufacturing and packaging details required for UC-2 (IDMP-465), to make manufactured item and pharmaceutical product disjoint, but both product specifications (IDMP-466), to change the status of this ontology to 'release' (IDMP-525), to add content related to dose forms (IDMP-531, IDMP-538), and to complete the set of ingredient roles specified in the implementation guide for ISO 11615 (IDMP-304). The https://spec.pistoiaalliance.org/idmp/ontology/ISO/20230501/ISO11615-MedicinalProducts.rdf version of this ontology was modified to (1) integrate content related to modifications from Figure 15 in ISO 11238 (IDMP-540), (2) support isotopes and nuclides as in ISO 11238, Figure 14 (IDMP-539), (3) integrate content related to therapeutic indications in ISO 11615 (IDMP-561), (4) clarify the definition of marketing authorization holder (IDMP-395), (5) refine restrictions between medicinal products and authorized medicinal products (IDMP-550), (6) aligne the ontology with the revised basis of strength pattern (IDMP-582), and (7) loosen a constraint on ingredient with respect to manufactured item (IDMP-602). The https://spec.pistoiaalliance.org/idmp/ontology/ISO/20230601/ISO11615-MedicinalProducts.rdf version of this ontology was modified to (1) make indication texts as nodes instead of literals (IDMP-591), (2) add the concept of shelf life / storage per Figure 11 in the ISO 11615 specification (IDMP-371), (3) add undesirable effect per Figure 14 in the ISO 11615 specification (IDMP-591), (4) rename 'has medical condition' to use a more aligned label with ISO 11615 (IDMP-591), (5) add the concept of route of administration (IDMP-614), and (6) integrate the refined pattern for controlled vocabularies (IDMP-533). The https://spec.pistoiaalliance.org/idmp/ontology/ISO/20230701/ISO11615-MedicinalProducts.rdf version of this ontology was modified to extend the definition of product role to relate to product specifications in addition to products (IDMP-633). + The https://spec.pistoiaalliance.org/idmp/ontology/ISO/20230801/ISO11615-MedicinalProducts.rdf version of this ontology was modified to add other therapy specifics (IDMP-639). Copyright (c) 2022-2023 EDM Council, Inc. Copyright (c) 2022-2023 Pistoia Alliance, Inc. @@ -793,7 +794,7 @@ - + @@ -808,7 +809,7 @@ - + @@ -991,6 +992,13 @@ 0 + + + + + 0 + + @@ -1684,6 +1692,62 @@ situation in which a patient experiences a pathological condition or disorder that impairs the body's normal functioning or its parts and is characterized by specific symptoms and/or signs + + + + + + + + + + + + + + + + + + + medication + role of a substance or product that is used in the treatment of a disease or symptom + + + + + + + + + + + + + + + + + + medication classifier + ISO 11615:2017 Health informatics - Identification of medicinal products (IDMP) - Data elements and structures for the unique identification and exchange of regulated medicinal product information, clause 9.9.2.6.3 + classifier for a medication by active substance or medicinal product(s) + Reference to a specific medication, which can be expressed as an active substance, Medicinal Product or class of Medicinal Products, as part of a specific indication or contraindication in accordance with the regulated product information shall be specified using an appropriate controlled vocabulary. The controlled term and the controlled term identifier shall be specified. + + + + + + + + + + + medication therapy + therapy in which a medication is administered to the patient + therapy with medication + + @@ -1962,6 +2026,27 @@ g) therapeutic indication(s) as authorized for the medicinal product.ISO 11615:2017 Health informatics - Identification of medicinal products (IDMP) - Data elements and structures for the unique identification and exchange of regulated information on substances, clause 3.1.56 + + + + + + + + + + + + + + + other therapy specifics + ISO 11615:2017 Health informatics - Identification of medicinal products (IDMP) - Data elements and structures for the unique identification and exchange of regulated medicinal product information, clause 9.9.2.6.1 + specification of the relationship between the indication or contraindication of a medicinal product with another therapy + If there is information about the use of the Medicinal Product in relation to other therapies described as part of the indication or contraindication in accordance with the regulated product information, this can be specified using this class. + other therapy relationship + + @@ -2750,6 +2835,13 @@ g) therapeutic indication(s) as authorized for the medicinal product.0 + + + + + 0 + + @@ -2793,6 +2885,64 @@ g) therapeutic indication(s) as authorized for the medicinal product.textual description of the therapeutic indications of a medicinal product + + + therapy + treatment of a patient + + + + + + + + + + + + + + + + + + + + therapy relationship + relationship that applies to a therapy or therapy specification + ISO 11615:2017 Health informatics - Identification of medicinal products (IDMP) - Data elements and structures for the unique identification and exchange of regulated medicinal product information, clause 9.9.2.6.2 + + + + + + + + + + + + therapy relationship type + classifier for a the relationship to a therapy or therapy specification + The type of relationship between the Medicinal Product indication or contraindication and a specific other therapy shall be specified using an appropriate controlled vocabulary. The controlled term and the controlled term identifier shall be specified. + ISO 11615:2017 Health informatics - Identification of medicinal products (IDMP) - Data elements and structures for the unique identification and exchange of regulated medicinal product information, clause 9.9.2.6.2 + + + + + + + + + + + therapy specification + specification of how a therapy is applied + therapeutic method + therapeutic procedure + therapy + + @@ -3137,6 +3287,32 @@ g) therapeutic indication(s) as authorized for the medicinal product.ISO 11615:2017 Health informatics - Identification of medicinal products (IDMP) - Data elements and structures for the unique identification and exchange of regulated information on substances, Figure 11 and clause 9.6.2.11 + + + has medication + + + + + + + + + + + relates to a medication or class of medications + ISO 11615:2017 Health informatics - Identification of medicinal products (IDMP) - Data elements and structures for the unique identification and exchange of regulated medicinal product information, clause 9.9.2.6.3 + + + + + has other therapy specifics + + + relates a therapeutic indication or contraindication to the specifics of another related therapy + ISO 11615:2017 Health informatics - Identification of medicinal products (IDMP) - Data elements and structures for the unique identification and exchange of regulated medicinal product information, clause 9.9.2.6 + + has package item quantity @@ -3289,6 +3465,14 @@ g) therapeutic indication(s) as authorized for the medicinal product.indication text + + + has therapy relationship type + + relates to a classifier of a therapy relationship + ISO 11615:2017 Health informatics - Identification of medicinal products (IDMP) - Data elements and structures for the unique identification and exchange of regulated medicinal product information, clause 9.9.2.6.2 + + has timing/duration @@ -3437,6 +3621,14 @@ g) therapeutic indication(s) as authorized for the medicinal product.is put in, taken in, or operated on by + + + is other therapy specifics of + + relates the specifics of another therapy to a therapeutic indication or contraindication + ISO 11615:2017 Health informatics - Identification of medicinal products (IDMP) - Data elements and structures for the unique identification and exchange of regulated medicinal product information, clause 9.9.2.6 + + is output of